Cirillo Nicola, Orlandi Massimiliano, Colella Giuseppe
Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, 3053 Victoria, Australia.
Department of Translational Medicine, Unit of Cardiology, Azienda Ospedaliero Universitaria University of Campania "Luigi Vanvitelli", Naples, Italy.
Transl Neurosci. 2022 Aug 22;13(1):236-239. doi: 10.1515/tnsci-2022-0240. eCollection 2022 Jan 1.
A possible association between Bell's palsy and COVID-19 vaccination has been suggested. While it is likely that COVID-19 vaccine recipients from the general population do have a slightly increased risk of developing Bell's palsy, there are little data regarding this risk in individuals with a history of disease. Gaining a better understanding of this association is particularly important for informing evidence-based recommendations regarding future booster shots in subjects who developed Bell's palsy as a side effect of vaccination, or as a result of SARS-CoV-2 infection. We previously described the first case of COVID-19 vaccine-related Bell's palsy; here we report an 18-month clinical and electromyographic follow-up and discuss the implications of receiving further vaccine doses in patients with positive disease history.
有人提出贝尔氏面瘫与新冠疫苗接种之间可能存在关联。虽然普通人群中接种新冠疫苗的人患贝尔氏面瘫的风险可能略有增加，但关于有疾病史的个体的这种风险的数据很少。更好地了解这种关联对于为那些因接种疫苗副作用或感染SARS-CoV-2而患贝尔氏面瘫的受试者未来加强针的循证建议提供依据尤为重要。我们之前描述了首例与新冠疫苗相关的贝尔氏面瘫病例；在此，我们报告了18个月的临床和肌电图随访情况，并讨论了有阳性病史的患者接种更多疫苗剂量的影响。
